Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F12%3A10126689" target="_blank" >RIV/00216208:11140/12:10126689 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00669806:_____/12:10126689

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S0091674912013061" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0091674912013061</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jaci.2012.07.053" target="_blank" >10.1016/j.jaci.2012.07.053</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Popis výsledku v původním jazyce

Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified ARas mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, andother health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommend

Název v anglickém jazyce

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Popis výsledku anglicky

Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified ARas mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, andother health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommend

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FN - Epidemiologie, infekční nemoci a klinická imunologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Allergy and Clinical Immunology

ISSN

0091-6749

e-ISSN

—

Svazek periodika

130

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

14

Strana od-do

1049-1062

Kód UT WoS článku

000310571400003

EID výsledku v databázi Scopus

—